787
Participants
Start Date
June 30, 2019
Primary Completion Date
February 23, 2022
Study Completion Date
September 26, 2022
Placebo
Placebo
Nemolizumab
Nemolizumab
Galderma Investigation Site 6228, Tbilisi
Galderma Investigational Site 6224, Tbilisi
Galderma Investigational Site 6235, Tbilisi
Galderma Investigational Site 6234, Tbilisi
Galderma Investigational Site 6147, Budapest
Galderma Investigational Site 5513, Budapest
Galderma Investigational Site 5448, Brussels
Galderma Investigational Site 6051, Sofia
Galderma Investigational Site 6078, Sofia
Galderma Investigational Site 6102, Sofia
Galderma Investigational Site 6165, Sofia
Galderma Investigational Site 6216, Sofia
Galderma Investigational Site 6046, Sofia
Galderma Investigational Site 6080, Sofia
Galderma Investigational Site 6079, Sofia
Galderma Investigational Site 6250, Sofia
Galderma Investigational Site 6236, Zugdidi
Galderma Investigational Site 6038, Leuven
Galderma Investigational Site 6162, Liège
Galderma Investigational Site 5567, Debrecen
Galderma Investigational Site 6026, Debrecen
Galderma Investigational Site 6254, Gyula
Galderma Investigational Site 6029, Pleven
Galderma Investigational Site 6251, Stara Zagora
Galderma Investigational Site 6062, Halle
Galderma Investigational Site 5140, Nice
Galderma Investigational Site 5442, Gera
Galderma Investigational Site 6053, Veszprém
Galderma Investigational Site 6164, Ghent
Galderma Investigational Site 8733, New York
Galderma Investigational Site 6068, Tallinn
Galderma Investigational Site 6069, Tallinn
Galderma Investigational Site 8723, Cortland
Galderma Investigational Site 6170, Martigues
Galderma Investigational Site 8741, Buffalo
Galderma Investigational Site 8721, Pittsburgh
Galderma Investigational Site 6155, Rozzano
Galderma Investigational Site 6041, Hamburg
Galderma Investigational Site 6150, Hamburg
Galderma Investigational Site 6040, Hamburg
Galderma Investigational Site 8896, Richmond
Galderma Investigational Site 6086, Kiel
Galderma Investigational Site 6168, Valence
Galderma Investigational Site 6180, Pavia
Galderma Investigational Site 8823, Greensboro
Galderma Investigational Site 8030, Raleigh
Galderma Investigational Site 8713, North Charleston
Galderma Investigational Site 6169, Toulouse
Galderma Investigational Site 8391, Hialeah
Galderma Investigational Site 8727, Hialeah
Galderma Investigational Site 8719, Miami
Galderma Investigational Site 8656, Miami
Galderma Investigational Site 8704, Miami
Galderma Investigational Site 8706, Miami
Galderma Investigational Site 8875, Delray Beach
Galderma Investigational Site 8203, Tampa
Galderma Investigational Site 8839, Tampa
Galderma Investigational Site 8523, Largo
Galderma Investigational Site 8749, Birmingham
Galderma Investigational Site 8893, Birmingham
Galderma Investigational Site 8866, Guntersville
Galderma Investigational Site 6175, Vicenza
Galderma Investigational Site 6081, Goettigen
Galderma Investigational Site 8705, Chattanooga
Galderma Investigational Site 6145, Bologna
Galderma Investigational Site 6031, Düsseldorf
Galderma Investigational Site 6151, Parma
Galderma Investigational Site 6167, Nantes
Galderma Investigational Site 8747, Cincinnati
Galderma Investigational Site 8724, New Albany
Galderma Investigational Site 8554, Detroit
Galderma Investigational Site 6067, Tartu
Galderma Investigational Site 5482, Aachen
Galderma Investigational Site 6082, Bonn
Galderma Investigational Site 6084, Mainz
Galderma Investigational Site 6143, Pisa
Galderma Investigational Site 5031, Lille
Galderma Investigational Site 8729, Rolling Meadows
Galderma Investigational Site 6083, Frankfurt
Galderma Investigational Site 6141, Chieti
Galderma Investigational Site 6045, L’Aquila
Galderma Investigational Site 5469, Heidelberg
Galderma Investigational Site 5407, Pierre-Bénite
Galderma Investigational Site 6198, Le Mans
Galderma Investigational Site 6133, Paris
Galderma Investigational Site 6166, Paris
Galderma Investigational Site 8618, Waco
Galderma Investigational Site 8807, Houston
Galderma Investigational Site 8003, Webster
Galderma Investigational Site 5382, Munich
Galderma Investigational Site 6197, Toulon
Galderma Investigational Site 8672, Salt Lake City
Galderma Investigational Site 8808, Scottsdale
Galderma Investigational Site 5566, Augsburg
Galderma Investigational Site 8825, Las Vegas
Galderma Investigational Site 8683, Los Angeles
Galderma Investigational Site 8906, Bell Gardens
Galderma Investigational Site 8745, Pasadena
Galderma Investigational Site 8905, Canoga Park
Galderma Investigational Site 8799, Ontario
Galderma Investigational Site 8577, Encinitas
Galderma Investigational Site 8658, San Diego
Galderma Investigational Site 8907, Newport Beach
Galderma Investigational Site 8820, Westminster
Galderma Investigational Site 8536, Santa Ana
Galderma Investigational Site 8673, Garden Grove
Galderma Investigational Site 8212, Portland
Galderma Investigational Site 8434, Seattle
Galderma Investigational Site 6124, Singapore
Galderma Investigational Site 6077, Singapore
Galderma Investigational Site 5499, Singapore
Galderma Investigational Site 8637, Farmington
Galderma Investigational Site 8506, Hackensack
Galderma Investigational Site 6135, Quimper
Galderma Investigational Site 6238, Tbilisi
Galderma Investigational Site 6227, Tbilisi
Galderma Investigational Site 6230, Tbilisi
Galderma Investigational Site 6132, Dresden
Galderma Investigational Site 6044, Roma
Galderma Investigational Site 6049, Roma
Galderma Investigational Site 6177, Rome
Galderma Investigational Site 5773, Bialystok
Galderma Investigational Site 6097, Chorzów
Galderma Investigational Site 5021, Katowice
Galderma Investigational Site 5362, Krakow
Galderma Investigational Site 6052, Krakow
Galderma Investigational Site 5363, Lodz
Galderma Investigational Site 5367, Lublin
Galderma Investigational Site 5377, Nowa Sól
Galderma Investigational Site 6063, Olsztyn
Galderma Investigational Site 6085, Poznan
Galderma Investigational Site 5495, Rzeszów
Galderma Investigational Site 6130, Szczecin
Galderma Investigational Site 6048, Tarnów
Galderma Investigational Site 6126, Warsaw
Galderma Investigational Site 5707, Warsaw
Galderma Investigational Site 6185, Wroclaw
Galderma Investigational Site 6096, Wroclaw
Lead Sponsor
Galderma R&D
INDUSTRY